ACUITYMD RAISES $80M AT $955M VALUATION
■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE
AcuityMD, an AI platform automating sales and CRM workflows for medtech companies, secured $80 million in Series C funding. The round valued the company at $955 million.
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.